| Genetic Factors in Age-Related Macular Degeneration (NCT00058695) | National Eye Institute (NEI) | 2003-04-04 |
| A Study to Evaluate rhuFab V2 in Subjects With Minimally Classic or Occult Subfoveal Neovascular Macular Degeneration (NCT00056836) | Genentech, Inc. | 2003-03-01 |
| An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD (NCT00058994) | Alcon Research | 2003-03-01 |
| Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate (NCT00349739) | University of Iowa | 2003-01-01 |
| Laser and Medical Treatment of Diabetic Macular Edema (NCT00050479) | National Eye Institute (NEI) | 2002-12-01 |
| Extension Study of rhuFab V2 in Subjects With Neovascular Age-Related Macular Degeneration (AMD) (NCT00095433) | Genentech, Inc. | 2002-09-01 |
| Efficacy of Electrical Micro-current Retinal Stimulation for Treatment of Dry Age-related Macular Degeneration (NCT01600300) | Acuity Medical International, Inc. | 2002-08-01 |
| Celecoxib to Treat Macular Degeneration in Patients Receiving Photodynamic Therapy (NCT00043680) | National Eye Institute (NEI) | 2002-08-01 |
| Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study (NCT00041444) | University of Wisconsin, Madison | 2002-06-01 |
| Phase 3 Study to Evaluate Anecortave Acetate vs. Visudyne for the Treatment of the Wet Form of AMD (NCT00041483) | Alcon Research | 2002-06-01 |
| Visudyne® in Occult (VIO) (NCT00121407) | QLT Inc. | 2002-03-01 |
| A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration (NCT00032396) | Control Delivery Systems | 2001-11-01 |
| Phase II/III Study of Anti-VEGF in Neovascular AMD (NCT00021736) | Eyetech Pharmaceuticals | 2001-07-01 |
| Identification and Treatment of Feeder Vessels in Macular Degeneration (NCT00018070) | National Eye Institute (NEI) | 2001-06-28 |
| Preventing Depression in Patients With Macular Degeneration (NCT00042211) | Thomas Jefferson University | 2001-02-01 |
| Fluocinolone Implant to Treat Macular Degeneration (NCT00008515) | National Eye Institute (NEI) | 2001-01-01 |
| Lutein for Age-Related Macular Degeneration (NCT00006202) | National Eye Institute (NEI) | 2000-09-01 |
| Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) (NCT00078221) | OccuLogix | 1999-08-01 |
| Complications of Age-Related Macular Degeneration Prevention Trial (NCT00000167) | National Eye Institute (NEI) | 1999-05-01 |
| Submacular Surgery Trials (SST) (NCT00000150) | National Eye Institute (NEI) | 1999-01-01 |
| Screening for Studies on Retinovascular Diseases (NCT00001733) | National Eye Institute (NEI) | 1998-03-06 |
| Phase I Study of Corticosteroid Treatment of Ill-Defined Choroidal Neovascularization in Age-Related Macular Degeneration (NCT00001615) | National Eye Institute (NEI) | 1997-07-01 |
| Long Term Follow-Up of Diabetic Retinopathy (NCT00001395) | National Eye Institute (NEI) | 1994-03-01 |
| Randomized Trials of Vitamin Supplements and Eye Disease (NCT00000161) | National Eye Institute (NEI) | 1993-08-01 |
| Diabetic Retinopathy and Visual Function Study (NCT00001346) | National Eye Institute (NEI) | 1992-11-01 |
| Age-Related Eye Disease Study (AREDS) (NCT00000145) | National Eye Institute (NEI) | 1990-09-01 |
| Randomized Trial of Beta-Carotene and Macular Degeneration (NCT00000152) | National Eye Institute (NEI) | 1982-04-01 |
| Macular Photocoagulation Study (MPS) (NCT00000158) | National Eye Institute (NEI) | 1979-02-01 |
| Branch Vein Occlusion Study (NCT00000162) | National Eye Institute (NEI) | 1977-07-01 |
| Study of AdGVPEDF.11D in Neovascular Age-related Macular Degeneration (AMD) (NCT00109499) | GenVec | |
| A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion (NCT00308477) | Sanwa Kagaku Kenkyusho Co., Ltd. | |
| Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab (NCT00804921) | University of Sao Paulo | |